Embecta (EMBC) Research & Development (2020 - 2026)
Embecta (EMBC) reported Research & Development of $5.4 million for Q1 2026, down 32.5% on a YoY basis from $8.0 million in Q1 2025, and up 17.39% sequentially from $4.6 million in Q4 2025.
Embecta (EMBC) Research & Development (2020 - 2026) Analysis & Trends
Embecta (EMBC) has 7 years of Research & Development data on file, last reported at $5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 32.5% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $19.0 million (down 72.26% YoY), and the FY2025 full-year result was $37.3 million, down 52.66% from the prior year.
- Research & Development rose to $5.4 million in Q1 2026, from $4.6 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $23.6 million in Q3 2023 to a low of $4.4 million in Q2 2025.
- A 5-year average of $15.4 million and a median of $18.0 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development jumped 58.04% in 2023 and sank 78.43% in 2025, its largest moves.
- Tracing EMBC's Research & Development over 5 years: stood at $16.9 million in 2022, then gained by 19.53% to $20.2 million in 2023, then grew by 0.5% to $20.3 million in 2024, then tumbled by 77.34% to $4.6 million in 2025, then grew by 17.39% to $5.4 million in 2026.
- Business Quant data shows EMBC's Research & Development at $5.4 million in Q1 2026, $4.6 million in Q4 2025, and $4.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | 19.80 Mn |
| Jun 30, 2024 | 20.40 Mn |
| Mar 31, 2024 | 18.40 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Sep 30, 2023 | 23.60 Mn |
| Jun 30, 2023 | 22.60 Mn |
| Mar 31, 2023 | 22.10 Mn |
| Dec 31, 2022 | 16.90 Mn |
| Sep 30, 2022 | 17.90 Mn |
| Jun 30, 2022 | 14.30 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 16.70 Mn |
| Sep 30, 2021 | 19.50 Mn |
| Jun 30, 2021 | 15.70 Mn |